Related Experiment Video

Updated: Aug 23, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

[Anti-leukotrienes in allergic diseases in children]

Anna Jung1

  • 1Wojskowy Instytut Medyczny, Klinika Pediatrii i Nefrologii Dzieciecej CSK MON w Warszawie.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|October 4, 2003
PubMed

Insights

Antileukotrienes show promise for treating childhood allergic diseases. These drugs target cysteinyl leukotrienes, which are implicated in airway inflammation and remodeling.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Pharmacology

Background:

  • Allergic diseases in children pose a significant health burden.
  • Inflammatory pathways in the airways are central to allergic conditions.
  • Leukotrienes are key mediators in allergic inflammation.

Purpose of the Study:

  • To review the current literature on antileukotriene use in pediatric allergic diseases.
  • To explore the role of cysteinyl leukotrienes in pediatric airway inflammation.
  • To assess the potential of antileukotrienes in managing these conditions.

Main Methods:

  • Comprehensive literature search of relevant studies.
  • Analysis of research on antileukotriene efficacy and safety in children.
  • Review of studies investigating leukotriene pathways in pediatric respiratory conditions.

Main Results:

  • Antileukotrienes are increasingly recognized for their therapeutic potential in pediatric allergic diseases.
  • Evidence suggests cysteinyl leukotrienes contribute to airway inflammation and bronchial remodeling in children.
  • Current literature supports the use of antileukotrienes as a treatment option.

Conclusions:

  • Antileukotrienes represent a valuable therapeutic class for managing allergic diseases in pediatric populations.
  • Targeting cysteinyl leukotriene pathways offers a promising strategy for controlling airway inflammation.
  • Further research may elucidate optimal use and long-term benefits in children.

More Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Humanized Mediator Release Assay as a Read-Out for Allergen Potency10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...